Navigation Links
Pam Marrone to Speak at Ag 2.0 Conference
Date:4/8/2011

DAVIS, Calif., April 8, 2011 /PRNewswire/ -- On April 12, at the Hilton San Francisco Union Square, Pam Marrone, Founder and CEO of Marrone Bio Innovations (MBI), will address Agriculture 2.0 conference attendees as part of an industry panel debating the topic of 'Feeding a Growing Global Population'. The discussion will explore technologies with the potential to curb environmental impact while producing enough food to feed a projected world population of 9 billion people by 2050.

Marrone's company, Marrone Bio Innovations, discovers, develops and markets effective and environmentally responsible products that fill unmet needs for weed, plant disease and invasive pest management. The company plays a leading role in developing and supplying effective, natural agricultural products that meet the challenge of delivering higher yields while maintaining a sustainable food production system.

In its 5th annual conference on April 11 & 12, 2011, Ag 2.0 brings together venture capitalists and early-stage companies, as well as senior decision makers in agribusiness and farmland funds, commodities experts, growth stage and institutional investors, and key industry insiders and policy makers. The conference provides a forum for hundreds of investors, entrepreneurs and industry experts to hold panel discussions, presentations, industry roundtables and networking sessions with individuals who will work to catalyze and capitalize sustainable agriculture as an asset class.

About Marrone Bio Innovations

Marrone Bio Innovations (MBI) discovers, develops and markets effective and environmentally responsible natural products that fill unmet needs for weed, plant disease and pest management. MBI's effective and safe products come from a combination of in-licensed technology and its own discovery. The company's own R&D finds naturally occurring microorganisms from unique habitats and develops them into pest management products. MBI has an impressive pipeline of new products waiting approval at the EPA, including two insecticides, two herbicides and Zequanox,™ a product for controlling invasive zebra and quagga mussels in fresh waterways. MBI has several new nematicide, insecticide, fungicide and herbicide candidates from its discovery screen.  In addition to its award-winning Regalia® Biofungicide, MBI currently markets GreenMatch®Burndown Herbicide for weed control in organic crop production.  For more information about Marrone Bio Innovations, please go to www.marronebio.com


'/>"/>
SOURCE Marrone Bio Innovations
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Marrone Bio Innovations to Present Invasive Mussel Control Solution
2. Marrone Bio Innovations Announces Two New Executive Appointments
3. Marrone Bio Innovations Named an IC20 Company
4. Pharma ChemOutsourcing 2011 Unveils First Wave of 50 Biotech Chemist Speakers for September 12-15 Show in New Jersey
5. Science advisor to the US EPA to speak to industry, academic leaders on sustainability innovations
6. PRA International Expert to Speak at China Drug Safety Summit
7. Tianyins Dr. James Jiayuan Tong is Invited to Speak at the CFO China Summit 2011 on January 19, 2011 at the St. Regis Hotel, Beijing
8. Accuray Incorporated to Speak at Seventh Annual Lazard Capital Markets Healthcare Conference
9. Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
10. Aneesh Chopra Joins 2010 mHealth Summit as Keynote Speaker
11. Bill Gates Named Keynote Speaker at the 2010 mHealth Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
(Date:3/22/2017)... , March 22, 2017  UBM and ... to announce their extended partnership and the third ... headlined by the 21 st Annual MassMEDIC ... taking place May 3-4, 2017. ... Technology Association (ADVAMED) President and CEO, Scott ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com ... ... cancer conditions are being pressured as of late due to ... cancer pain management has a dramatic impact on patient,s quality ... and development activities for identifying new forms of opioid formulations ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL ... live events series, “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help “no-option” ...
Breaking Biology Technology:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... 2017 Report Highlights ... The global synthetic-biology market reached nearly ... 2021, growing at a compound annual growth rate (CAGR) of ... the global markets for synthetic biology. - Analyses of global ... projections of compound annual growth rates (CAGRs) through 2021. - ...
Breaking Biology News(10 mins):